Main
>
ONCOLOGY (**)
>
Leukemia>Lymphoblastic>Acute>Ph+***
>
Treatment
>
Co.: USA. A. Ponatinib
>
Mechanism: BCR-ABL inhibitor
Mechanism: BCR-ABL inhibitor's products
This section has no products